Histochemical localization of kallikrein-like Pro-Phe-Arg-naphthylester esterase activity in the rat kidney

VARIATIONS IN KALLIKREIN-LIKE ESTERASE ACTIVITY IN DIFFERENT SEGMENTS OF THE RAT NEPHRON DURING SALT-LOAD AND SALT-DEPLETION

Histochemical changes in kallikrein-like activity in the rat nephron induced by chronic salt-load or salt-depletion were investigated semiquantitatively, using a synthetic substrate for kallikrein, pro-phe-arg-naphthylester. The location of the changes in the different segments of the nephron was established by comparison with neighbouring freeze-dried sections, where the various structures of the tubular segments were identified. The enzyme activity was graded semiquantitatively and the percentage of tubular segments possessing enzyme activity was recorded. In salt-loaded rats, the enzyme activity in the deep half of the renal cortex was decreased in the first and second segments of the proximal tubule as well as in the third segment in the cortex. In salt-depleted rats, the enzyme activity in the deep half of the renal cortex was also decreased in the first segment of the proximal tubule as well as in the third segment in the cortex. In contrast, the enzyme activity in the second segment of the proximal tubule was increased in the superficial cortex as well as in the deep cortex. Furthermore, in the salt-depleted rats the enzyme activity was decreased in the cortical part of the ascending thick limb of Henle, but increased in the medullary part. In the superficial part of the cortex, the enzyme activity was decreased in the distal convoluted tubule. In the kidneys from both salt-loaded and salt-depleted rats, the differences in enzyme activity between zones--such as found in the normal kidney--disappeared in the case of the first and second segments of the proximal tubule. However, in the other segments of the nephron, the zonal differences were preserved in both experimental conditions.

Response of isolated rat descending vasa recta to bradykinin

Outer medullary descending vasa recta (OMDVR) were dissected from the outer medullary vascular bundles of young rats, perfused in vitro, and loaded with fura 2 for measurement of intracellular calcium concentration ([Ca2+]i) by fluorescent ratio imaging. Fluorescent video images revealed that fura 2 selectively loads into endothelial cells but not pericytes. Bradykinin (BK), at concentrations > 10(-11) M, elicited an increase in [Ca2+]i from baseline values in the range from 50 to 100 nM to peak values of 600-800 nM followed by a sustained plateau of 150-250 nM. The vasopressin V1-receptor agonist [Phe2,Ile3,Orn8]vasopressin constricted OMDVR but yielded no observable [Ca2+]i response, a finding that is consistent with an endothelial cell origin for the fura 2 fluorescent signal. The BK [Ca2+]i response was blocked by the selective BK B2-receptor antagonists D-Arg-[Hyp3,Thi5.8,D-Phe7]BK and D-Arg-[Hyp3,D-Phe7,Leu8]BK but not the B1 antagonist des-Arg9-[Leu8]BK. BK vasodilated microperfused OMDVR that had been preconstricted with 10(-8) M angiotensin II. We conclude that the [Ca2+]i response of OMDVR endothelia can be selectively studied with fura 2, that BK increases endothelial [Ca2+]i via the B2 receptor, and that BK can vasodilate descending vasa recta.

Selective action of androgens on the molecular forms of esterases characterized by two-dimensional gel electrophoresis in the epididymis and vas deferens of the mouse

Molecular forms of esterases were resolved in non-denaturing conditions by using two-dimensional gel electrophoresis with isoelectric focusing in the first dimension and a time-dependent polyacrylamide gradient gel electrophoresis (PAGGE) in the second dimension. This procedure was used to analyse sequential changes in esterase composition along the excurrent genital duct of the mouse and to initiate a specific identification of the androgen-regulated molecular forms. Almost all the 68 variants (pH 3.9-6.4 and 50-300 kDa) revealed by alpha-naphtyl acetate from the fluids of the three parts of the epididymis (caput, corpus, cauda) and vas deferens, could be assigned to the carboxylesterase group as shown by their action on various substrates and sensitivity to inhibitors. Some of these variants co-migrated with those in the serum and testis, whereas other enzyme forms made their first appearance in the caput (13), in the corpus (26) and in the vas deferens (3). The major changes occurred between the caput and the corpus of the epididymis. Only a few acidic spots were not revealed after neuraminidase digestion. Castration of mice (4 weeks) resulted in inhibition of the activity of 34 esterase forms, and thus abolished most of the regional differences in the excurrent duct system. By re-initiating or repressing the synthesis of regional esterase variants, testosterone supplementation (2 and/or 4 weeks) of castrated animals restored the normal esterase pattern in the three epididymal parts, but not in the vas deferens. The major effect of efferent duct ligation (4 weeks) was the emergence in the corpus and cauda of the epididymis of two variants found in the caput of uncastrated mice.

Rat urinary kallikrein localization in kidney: effects of fixation

The influence of fixation on the immunocytochemical localization of tissue kallikrein in the kidney has been evaluated using both monoclonal and polyclonal antibodies. These studies have provided several results relevant to kallikrein localization in kidney: (1) the intensity and distribution of immunostaining with both polyclonal and monoclonal anti-kallikrein antibodies is fixation-dependent; (2) the most intense and consistent localizations of kallikrein are in the connecting tubule and the cortical collecting duct of the nephron; (3) kallikrein-like immunoreactivity is seen in proximal tubules with polyclonal but not with non-cross-reactive monoclonal antibodies; and (4) fixatives which disrupt membranes reveal a kallikrein-like antigen in straight tubules of the outer medulla. However, immunostaining with monoclonal antibodies indicates that much of the observed immunostaining at this site probably represents cross-reactivity with another member of the kallikrein family of enzymes.

Electrophoretic characterization of mouse epididymal esterases in inbred lines and in a natural population

Esterase isozymes were studied in mouse epididymis of two inbred strains (C57BL, DBA/2) and in a natural population (Swiss OF1), by using vertical polyacrylamide gel electrophoresis and staining with alpha or beta-naphthyl acetate as a substrate. Eighteen (C57BL), 17 (DBA/2) or 16 (Swiss OF1) epididymal isozymes were separated; four were common to the testis, and five to both the testis and the serum. The use of different inhibitors showed that carboxylesterase activities account for the greater part of the total epididymis non-specific esterase activity. This comparative study revealed minor interspecies variations since only two isozymes were not expressed in the same manner in the three populations examined. Among the nine isozymes which appeared solely in the epididymis, the profiles varied between tissues and fluids as well as between the proximal part in which sperm maturation occurs and the distal part where sperm storage takes place. The variations proceeded from the relative activity of isozymes and the presence or absence of some of them; two characterized the proximal part and one the distal part in the three species. By comparing testis and epididymal tissues and fluids, it is suggested that the isozymes found in epididymal fluids originated from the testis, the epididymal epithelium or both. In addition to this epididymal secretory function, the lack in the fluid of the distal part of one isozyme identified in the testis, and two in the proximal part may also provide evidence for its reabsorptive function.

New synthetic substrate for kallikrein and its application

We developed a new synthetic substrate, Pro-Phe-Arg-alpha-naphthyl ester, for kallikrein. We found that this substrate had higher specificity and sensitivity for kallikrein and was applied for the preparation of zymogram and for the histochemical demonstration. With Pro-Phe-Arg-alpha-NE as substrate, the minimum detectable concentration of human urinary kallikrein was about 0.001 KU and then kallikrein could be determined with 25 microliter of human urine. We also found the possibility that occurring of abnormalities during pregnancy were predicted by the determination of urinary kallikrein of pregnants. Zymograms were prepared for various kinds of kallikrein using this substrate. The localization of kallikrein-like enzyme in rat kidneys was defined by the application this substrate for histochemistry. Moreover, cytochemical demonstrations of leucocytes in human blood were done using Ts-Lys-alpha-NE and Ac-Tyr-alpha-NE.

Localization of kallikreins in the human parotid gland and in the human kidney: a comparative study of immunohistochemistry and enzyme histochemistry

Kallikreins were localized in the human parotid gland and in the human kidney from two different aspects of the enzyme: the enzyme antigenicity and the enzyme activity. In the human parotid gland, the kallikrein antigenicity and the enzyme activity were identical in their locations in the ductal cells. In the human kidney, however, the enzyme activity was revealed in the proximal tubule without any corresponding kallikrein antigenicity. Therefore, this activity may be due to esterases other than kallikreins. The Kallikrein antigenicity was found to be located in the basement membrane of tubules, in the interstitium as well as in some granules of the proximal tubule. These results are compatible with tissue kallikreins being formed in the ducts of the human parotid gland and suggest that circulating tissue kallikreins in the plasma are deposited in the human kidney.

Subcellular localization of renal kallikrein by ultrastructural immunocytochemistry

The subcellular distribution of immunoreactive kallikrein was described in the rat nephron using ultrastructural immunocytochemistry. The renal tissue was fixed with a mixture of buffered picric acid-paraformaldehyde-glutaraldehyde and immunostained with the peroxidase-antiperoxidase method for the electron microscope with the following steps: antikallikrein antiserum, anti-IgG serum, peroxidase-antiperoxidase complex, 3-3' diaminobenzidine-H2O2, and post-staining with osmium tetroxide. Preabsorption of the primary antiserum with purified rat urinary kallikrein and substitution with normal serum were used as controls. As we have described previously, kallikrein was present exclusively in the connecting tubule cell of the distal nephron. Subcellularly, kallikrein was distributed in luminal membranes, basal membranes, rough endoplasmic reticulum, Golgi apparatus, and vesicles. The immunoreactive vesicles were present in the proximity of the Golgi apparatus and in the cytoplasm in the way between the Golgi and the luminal and basal plasma membranes. No immunostaining was observed in other subcellular components of the connecting tubule cell or in the other type of cell. With the description of kallikrein in subcellular organelles involved in the synthesis, processing, and transport of glycoproteins, we have advanced an hypothetical intracellular processing pathway for renal kallikrein.

Enzyme- and immuno-histochemical localization of kallikrein. II. The human kidney

Localization of kallikrein in the human kidney was investigated by two markers: kallikrein-like activity and kallikrein antigenicity. Kallikrein-like activity was demonstrated enzyme-histochemically by using a synthetic substrate for kallikrein, pro-phe-arg-naphthyl-ester. Kallikrein antigenicity was demonstrated by the unlabelled antibody peroxidase-antiperoxidase method using an antiserum against human urinary kallikrein. The kallikrein-like activity was localized in the proximal tubular cells without any corresponding kallikrein antigenicity. Neither kallikrein-like activity nor kallikrein antigenicity was noticed in any other tubular cell. These results are contrary to those in the ductal cells of the human parotid gland where the kallikrein-like activity and the kallikrein antigenicity were identical in their locations. The peroxidase-antiperoxidase method revealed, for the first time, kallikrein antigenicity both in the interstitium and in the basement membrane region of Bowman's capsule and of all the tubules, possibly representing circulating glandular kallikreins deposited in the renal tissue. Thus, the present findings are consistent with the hypothesis that the urinary (renal) kallikreins are derived from circulating glandular kallikreins.

Enzyme- and immuno-histochemical localization of kallikrein. I. The human parotid gland

Localization of kallikrein in the human parotid gland was investigated simultaneously by two markers: kallikrein-like (enzyme) activity and kallikrein antigenicity. Kallikrein-like activity was histochemically demonstrated by using a synthetic substrate, pro-phe-arg- naphthylester . Kallikrein antigenicity was demonstrated by an unlabelled antibody peroxidase-antiperoxidase method, where monospecific antiserum against highly purified urinary kallikrein was used as the primary antiserum. The results showed that kallikrein-like activity and kallikrein antigenicity were identical in their locations in the ductal cells, being localized in the luminal part of the striated ducts and to a lesser degree in the excretory ducts. This indicates the presence of active kallikrein in these regions. No enzyme activity nor antigenicity was observed either in acini or in intercalated ducts. Moreover, the peroxidase-antiperoxidase method revealed kallikrein antigenicity for the first time extracellularly in the basement-membrane region of acini and of ducts as well as in the interstitium surrounding ducts and major vessels.